Post No: 635042 January 07, 2018, 11:10PM
Guest wrote: 1 Reply

Nutra Pharma Corp [NPHC] biotech values

FDA approved stage II anti-inflammatory pain medicine - NYLOXIN

Orphan drug status for a pediatric MS medicine moving into to trials

funding and potential new jv.

Type the characters that you see in the box (5 characters).